Jane Street Group, LLC Puma Biotechnology, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2020 Feb 17, 2021	BUY	$7.78 - $12.13 $16,338 - $25,473	2,100 Added 6.71%	33,400 $343,000
Q3 2020 Nov 17, 2020	BUY	$9.5 - $11.14 $159,600 - $187,152	16,800 Added 115.86%	31,300 $316,000
Q2 2020 Aug 17, 2020	BUY	$7.01 - $13.24 $21,731 - $41,044	3,100 Added 27.19%	14,500 $151,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $55,900 - $92,278	-8,600 Reduced 43.0%	11,400 $100,000
Q2 2018 Aug 15, 2018	BUY	$48.3 - $68.25 $966,000 - $1.37 Million	20,000 New	20,000 $1.18 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $137,310 - $228,275	-2,300 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$93.85 - $132.45 $797,725 - $1.13 Million	-8,500 Reduced 78.7%	2,300 $227,000
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $777,600 - $1.29 Million	10,800	10,800 $1.29 Million

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.